-
MODA-EM Paperless Solution to be Implemented at UK Vaccines Manufacturing Centre
americanpharmaceuticalreview
December 21, 2020
Lonza and the Vaccines Manufacturing and Innovation Centre (VMIC) announced a project to implement the MODA-EM™ Solution to automate quality control (QC) in the new facility.
-
UK’s VMIC to Implement Lonza’s MODA-EM
contractpharma
December 09, 2020
The Vaccines Manufacturing and Innovation Centre in Oxfordshire (VMIC), UK has selected Lonza’s MODA-EM Solution to digitize its Microbiology Quality Control operations.
-
DWK Life Sciences Partners with VMIC
contractpharma
October 10, 2020
DWK Life Sciences has entered a supply chain agreement with the UK’s Vaccines Manufacturing and Innovation Centre (VMIC) that will see the company provide primary packaging – in the form of borosilicate pharmaceutical glass vials – to the organization.
-
UK Prime Minister visits the UK Vaccines Manufacturing and Innovation Centre (VMIC)
europeanpharmaceuticalreview
September 22, 2020
Prime Minister Boris Johnson visited the construction site of the VMIC and met scientists and engineers at the forefront of the UK’s COVID-19 response.
-
Oxford Biomedica Signs Collaboration Agreement with VMIC
contractpharma
June 15, 2020
Will work collaboratively to enable the manufacture of viral vector-based vaccines.
-
Oxford Biomedica partners VMIC for vaccine manufacturing
pharmaceutical-technology
June 09, 2020
UK-based gene and cell therapy group Oxford Biomedica has partnered with non-profit Vaccines Manufacturing and Innovation Centre (VMIC) for the manufacturing of viral vector-based vaccines.
-
UK provides funding support for Covid-19 vaccine programme
pharmaceutical-technology
May 19, 2020
The UK Government has committed to providing £84m in funding and manufacturing support to researchers working on Covid-19 vaccine programme, said Business Secretary Alok Sharma.
-
UK to invest up to 93 million pounds in new coronavirus vaccine centre
expresspharma
May 19, 2020
The funding will ensure the new centre opens in Summer 2021, a year ahead of schedule, the department said.
-
New Vaccines Centre a ‘major commercial opportunity’
pharmatimes
December 06, 2018
Business Secretary Greg Clark MP has announced the UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC), said to represent a “major commercial opportunity”, and also a new front line in the nation’s defence against global pandemic threats.